Intramural methotrexate therapy for the prevention of neointimal thickening after ballon angioplasty  by Muller, David W.M. et al.
460 
JACC Vol. ZQ, Nc. 2 
August 1992:460-6 
DAVID W. M. MULLER, MBBS, FRACP, FACC, ERIC J. TOPOL, 
STEPHEN G. ELLIS, MD, FACC” 
Ann Arbor, Michigan nnd Cleveland, Ohi0 
@je&ves. The study was performed to test the hypothesis that 
h local, intramural concentr~tians of am~~neQ~~aSt~C agents at 
she of balloon injury inhibit vascular smooth muscle cell 
proliferation without systemic toxicity. 
kc&grourrd. The pr~ern~nant m~han~sm for recurrent sb- 
nosls after coronary halloon angioplasty is n~~~tirnal thickening 
due to medial smooth muscle cell proliferation. The clinical use of 
potent antipro~ifer~~ive agents to prevent restenosis ha  been 
the ptential for severe systemic side effects. Local 
therapy with these agents may be effective and free of systemic 
complications. 
&ho&. Afler biiateral balloon angioplasty of the carotid 
arteries of 14 juvenile farm pigs, the dilated arterial segments 
were trected locally with methotrexate (6.25 mglml, total dose 
25 mg) or 0.9% saline solution through a perforated balloon 
catheter. The animals were then killed 30 days 
to determine the effects of this therapy on neoi 
an additional six animals, Mum-labeled methotrexate was used 
to determine the concentration and duration of detectability of 
methotrexate in the wall of the treated arteries nnd in the systemic 
circulation. 
Balloon aopioplasty of atheromatous coronary artery steno- 
ses is followed by recurrent stenosis at the site of arterial 
iqjury in 35% to 40% of patients (1.2). The predominant 
cause is formation of a tibrocellular neointima (3-5). The 
cellular events that characterize the fibroproliferative re-
sponse to arterial injury have been well described. They 
include the deposition ofplatelets on the disrupted endothe- 
lial surface, the r lease of mitogenic factors from platelets 
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meth~~rexate.treated arteries and tbe 18 saline-trea~c 
ered through a pe~ora 
pears to be a promising means of delivering a h 
and monocytes. the proliferation and migration of smooth 
muscle cells from the media to the intima and, finally, the 
synthesis and secretion of connective tissue matrix (6.7). 
Conventional pharmacologic therapies directed at the inhi- 
bition of platelet activation, thrombus formation or vasocon- 
striction have failed to reduce the incidence of restenosis in 
clinical studies (g-12). Antiproliferative therapies have been 
inadequately evaluated in clinical studies, principally be- 
cause of the possibility of life-threatening systemic side 
effects. One potential means of avoiding these side effects 
was recently described by Wolinsky and Thung (13). These 
investigators used a specially designed perforated balloon 
catheter to inject fluids directly into the wall of canine 
brachial arteries. Fluoresceinated heparin, infused through 
the catheter, ~3s shown to be uniformly distributed through- 
out the arterial wall for at least 48 to 72 h. 
We hypothesized that with the use of the perforated 
balloon catheter, high intramural concentrations of a potent 
antiproliferative drug could be achieved at the site of balloon 
angioplasty and that this local pharmacologic therapy might 
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perforated infusion balloon catheter. lnfusate is
tly into the arterial wall through 
Reprinted, with ~~r~issio~, fr 
uscle sell ~~a~iferatio~ alid reste- 
nosis without a s~g~ifica~~t risk of systemic side effects. Of 
the antineoplastic drugs cdl only uS:.d to treat ma~~~oant 
and has been successfully used to tlkat of a 
nonmalignant conditions including psoriasis, 
thritis and hepatic cirrhosis. 
The principal aims of this study, therefore, were 1) to 
deternli~e the duration of detectability, and to estimate the 
concentration, of methotrexate in the arterial wall after 
delivery through a perforated balloon catheter, and 2) to 
determine the effects of local intramural methotrexate ther- 
apy on the extent of neointimal t~~ckeoi~g after balloon 
angioplasty elf porcine carotid arteries. 
The study was performed with the 
approval of the University of ichigan Committee on the 
Use and Care of Animals and was conducted irk two phases. 
In the first phase, tritium-labeled methotrexatc was used to 
estimate the concentration f methotrexate at the site of 
infusion of the drug through the balloon catheter over 14 
days. In the second phase, the effect of this therapy on the 
degree of neointimal thickness was determined 30 days after 
balloon dilation. The drug delivery system used in the study 
was the Wolinsky infusion balloon catheter (USC1 Division 
of CR Bard Inc.). The catheter has a 4.3F triple-lumen shaft 
with a distal balloon made of polyethylene t traphthalate. 
The balloon (Fig. 1) has 28 holes (25 pm in diameter, in 
longitudinal s) through which the infusate is delivered. 
Ex~erim~ protocol. The study protocol was similar in 
the two phases. After sedation with telazol (6 mglkg body 
weight) and xylazine (2.2 mglkg), juvenile Yorkshire farm 
pigs weighing 18 to 28 kg were intubated and Fnesthetized 
with 1% halothane. Access to the carotid ,rteries was 
obtained by cutdown through a midline cervical incision. 
ameter of each artery 
lumen was estimated 
id balloon angioplasty and infusion of radiolabeled 
was diluted with 0.9% saline solution to a concentratioli f 
12.5 @I/ml. Over 30 to 60 s, a total dose of40 &i of labeled 
methotrexate was infused at a pressure of 5 to 6 atm through 
the perforated balloon catheter into the leftcarotid artery at 
the site of balloon angioplasty. An equivalent volume of 
0.9% saline solution was infused into the opposite carotid 
artery by using the same inflation variables. Each of the six 
pigs was then killed under general anesthesia with a lethal 
entothal Sodium at a different time interval (2, 24, 
48 or 72 h or 7 or 14 days) after instillation of the labeled 
drug. 
Each carotid artery vas then resected, and a blood 
sample was obtained for determination f the circulating 
tritiated methotrexate activity. The arterial specimens, 
trimmed to include only the length of the balloon-injured 
segment, and the blood samples were then weighed and 
individually oxidized in a sample oxidizer (Packard lnstru- 
ment Company, model 306). The resulting water vapor was 
collected, condensed and transferred toa liquid scintillation 
counter (Packard Instrument Company, model 4530) for 
ldetermioation of the beta-emitting activity of t 
water. The activity, expressed as PCilg of tissue, was 
determined by using the measured countslmin, the known 
half-life of tritium, the dose delivered and the elapsed time 
from instillation to the animal’c death. 
base 2. In the second phase, 10 pigs underwent bilateral 
carotid balloon angioplasty and infusion of methmexate 
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(6.25 mglml) into the left carotid artery through a perforated 
balloon catheter with a b lloon diameter of3 or 3.5 mm. A 
total of 4 ml (25 mg) was infused at a pressure of 5 to 6 atm 
over 30 to 60 s. An equivalent volume of normal saline 
solution was infused over the same period and at the same 
pressure into the contralateral artery. After completion of 
the procedure, a blood sample was obtained for determina- 
tion of the systemic methotrexate level. Because of the 
possibility that he contralateral untreated artery might ake 
up circulating methotrexate, four additional pigs underwent 
bilateral angioplasty and arterial infusion of 0.9% saline 
solution to serve as “true controls.” Each of these 14 pigs 
was then killed 30 days after the angioplasty and infusion 
procedures. 
fstologic analysis, In each phase of the study, the ani- 
mals were killed under general nesthesia with a lethal dose 
of intravenous Pcntothal Sodium. The carotid arteries were 
exposed and perfusion fixed in situ with 10% neutral buffered 
formaldehyde. The balloon-injured arterial segments were 
then resected, paraffin-embedded, s ctioned and stained 
with hematoxylin-eosin and Movat pentachrome stains. The 
morphologic features of the treated and nontreated arterial 
segments were compared by an experienced pathologist 
(G.D.A) who was unaware of the treatment given to each 
arterial segment. The extent of neointimal thickening, mea- 
sured from the internal elastic lamina to the lumen surface at 
the point of maximal thickening, was determined for each 
arterial segment by using an ocular micrometer. Intimal 
thickness was also measured at circumferential points 90°, 
180” and 270” from the point of maximal thickening: and the 
four measurements were averaged togive a mean intimal 
thickness. 
Statistics. All values are recorded as the me*111 value 5: 
SEM unless otherwise stated. Comparisons of the severity 
of maximal nd mean intimal thicknesses were performed by 
using the Mann-Whitney U and Kruskal-Wallis tests. A 
two-tailed p value ~0.05 was considered to be statistically 
significant. The sample size was chosen to give a power of 
8O’+S to detect a 50% reduction i  intimal thickness in the 
treated group by using an assumed control neointimal thick- 
ness of 250 pm. 
Duration of methotrexate activity. The activity of tritium- 
labeled methotrexate in the treated carotid artery at each 
time interval is shown graphically in Figure 2. Two hours 
after instillation of the labeled methotrexate, he tissue 
activity WBS 10.4 j&i/g (2.14 X 10m4 hmollg). At the same 
time interval, the activity in the saline solution-treated 
contrzdateral artery was 0.38 ,&Yg. The activity in the 
treated artery decreased over the 1st 24 h io 3.9 &i/g but 
mGwi >2.5 &i/g at each interval from 24 h to 7 days 
(Fig. 2). At 14 days, the level was 0.33 @i/g. In the saline 
solution-treated contralateral c rotid artery, the activity &O 
Figure 2. Time-activity curve of tritium-labeled methotrexate lex- 
pressed as $3/g of tissue) in the treated carotid arteries. 
decreased over the 1st 24 b and subsequently remained 
co.04 $.Yg at each time erval . 
T-he rcltio qfactivity irl t treared cnrotid artery to lkar irr 
3A. Two hours after instillation of :he labeled met 
the tissue concentration of methotrexate was >!. 
greater than the blood concentration. The ratio decreased 
over the 1st 48 h but remained >50: 1for the 1st 7 days. Two 
weeks after methotrexate instillation, the tissue activity was 
approximately the same as the activity in the circulating 
blood (Fig. 3A). Similarly, the tissue activity of labeled 
methotrexate was considerably greater in the treated than in 
the nontreated carotid artery for at least 7 days and remainec 
approximately 25times greater 14 days after drug instillatiorl 
(Fig. 3B). 
ct on ~eointima~ t ickening. Ten pigs were treated 
unilaterally with methotrexate in the second phase of the 
study and were allowed to survive for 30 -’ 1 days postop- 
eratively. In these animals, the serum methotrexate level, 
measured I h after completion of the drug instillation. was 
1.15 + 0.31 ~mollliter. Because of the nature of the study 
Figure 3. A, Ratio f the activity of labeled methotrexate in the 
treated left carotid artery and in the circulating blood over the 
Zweek study period. , Ratio of the activity of labeled methotrexate 
in the treated left and untreated right carotid arteries. 
0 2 4 6 8 10 12 14 
Time (days) 
phase 1ofthe study, was noted to have complete hrombotic 
occlusion of ne arterial segment. 
The rernailling 21 urteries ~~~~~I~~~eQt~~~~ mow typicak 
ofjibrocelldar neointimal thickenitrg. In these vessels, the 
proliferative response was commonly eccentric and was 
usualIy maximal in proximity to a region of apparent disrup- 
tion of the interna! elastic lamina nd adjacent media (14). In 
one artery (Fig. 4A), the internal and external e astic laminae 
were disrupted with features uggestive of tratima induced 
by a high pressure j t from the perforations of the balloon 
catheter, In the remaining arteries, only partial thickness 
apparent. The neointima ppeare 
geneous population of cells. Although 
al stains were not used to confirm cell 
types, the appearances frequently suggested not only prolif- 
eration of smooth muscle cells but also heavy infiltration of 
the lesion by macrophages, often laden with hemosiderin. 
occurring singly or as foreign body giant cells. The presence 
of the latter cells suggests hat foreign particulate matter may 
have been i troduded into the arterial wall from the balloon 
catheter. Calcification, observed in two vessels, occurred in 
both the media and the n ointima (Fig. 413). 
The mean intimal thickness was determined in each 
artery by using measurements at point of maximal 
thickness and in the remaining three rants. The maximal 
thickness was 195 5 112 ~r-ea in the methotrexate-treated 
group compared with 148 -C 74 pm in the saline-treated 
arteries (p =0.6); the mean intimal thicknesses were 59 + 
30 Frn and 56 5 25 pm, respectively (p = 0.16) (Fig. 5). 
There were no significant differences in maximal or mean 
intimal thickness between the “true control” and group and 
A, Eccentric intimal thickening in close proximity to a 
breach in both the internal and external etastic laminae in a 
methotrexate-treated artery. The lesion IS composed predominantly 
of smooth muscle cells and connective tissue mxirix but also has a 
moderatrtlw heavy iafiltrarion of hemosiderin-laden macrophagtj 
(arrow) ahacent to the lumen surface ( ovat stain). Reprinted, with 
permission, from Muller et al. (14). , The contralateral saline- 
treated artery of the same animal. A similar degree of intimal 
thickening is present. The neointima contains foci of calcification 
with foreign body giant cell? CWPOW). The underlying internal elastic 
lamina and media appear reiatively normal (Movat stain). 
the group with inftision of saline solution into the contralat- 
era1 artery. Similarly, no difference between the groups was 
appdrcnt if the pigs with atypical histologic findings (minimal 
injury or organizing thrombus) were excluded from the 
analyses. 
re of 
t iwg. The principal findings of this study were that, 
with the use of the perforated balloon catheter, high tissue 
concentrations of methotrexate were achieved inthe arterial 
wall at the site of balloon injury and remained present fc~ at 
least 7 days. Despite this treatment, there was LO difference 
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urc 5. Meat? intimal thickness (fin11 in the methotrexate-treated 
(MTX), and saline-treated (control) carotid arteries. Differences 
bctwcen the two groups were not statistically significant. 
in the degree of the neointimal thickening in the treated and 
nontteated carotid artcties 30 days after balloon injury. The 
morphologic appearance of the neointima, although some- 
what heterogeneous, was also similar in each of the groups; 
there was no evidence of an adverse effect of the methotrex- 
ate therapy. It is possible, however, t:lat the perforated 
balloon catheter may have contributed to the degree of 
arterial injury. In one pig, the morphologic features sug- 
gested that the high pressure jets of the balloon catheter had 
caused transmural arterial injury with disruption of both the 
internal and the external elastic laminae. Several potential 
mechanisms may explain the apparent failure of local an- 
tiproliferative therapy to prevent trauma-induced neointimal 
thickening. These mechanisms include an inadequate tissue 
concentration of methotrexate, nonuniform distribution of 
dlug within the arterial wall, an inadequate duration of 
antiproliferativc therapy, thickening of the neointima by 
infiltration of nonprotiferating cells or thrombus and the 
detrimental effects of inhibition of cndothelial cell regenera- 
tion. 
Cun~nt~~t~~~ and duration of therapy. The findings of 
the first phase of the study suggest that high concentrations 
of methotrexate were present in the arterial wall for at :east 
7 days. The optimal therapeutic blood concentrations of 
methotrexate in malignant neopiasms for which methotrex- 
ate is commonly used are iisted in Table I (15). The 
estimated intramural methotrexate concentration of 100 to 
I800 pmol/liter is comparable to the order of magnitude of 
the peak seru n methotrexate concentrations recommended 




Malignant Neoplasm (pmollliter) 
Osteosarcoma I .a00 
Large cell adenocarcinoma loo 
Lymphoma IO 
Choriocarcinoma I 
for the treatment of the least responsive malignant neo- 
plasms, such as large cell adenocarcinoma and osteosar- 
coma. Thus, the local concentrations ofmetbotrexate should 
have been adequate to achieve an a~t~~rol~ferat~v~ effect for 
at least I week. Whether the drug was uniformly distribute 
within the arterial wall is less clear. Althougb Wotiusky an 
Thung (13) showed a uniform distribution of fluoresceinated 
heparin and horseradish peroxidase throughout the full 
thickness of the canine arterial walls after delivery through 
thi; satne perforated balloon catheter, the distribution of 
methotr arteries in this study is u 
known. as a small motecular weig 
(450 dahons), allowing it t tiuse readily, and is activ 
taken up across the cell ~lembraue. It is not easonable to 
assume, therefore, that the distribution of drug would 
have been similar to that shown with other agents in previ- 
ous studies. 
What tiUk inl etwl imstitirlrs Ntf ctd&qrtale ~itt~(tli(ttt qf 
thmpy in this tnodd of twcwosis is also rrnknowtr. It is 
known from careful stildics pcrfoh ,ned by CIowes et al. (16) 
that medial smooth muscle cell division begins between 24 
and 72 h after balloon denudation of rat carotid arteries and 
is followed soon by migration of the proliferating cells from 
the media to the intima. In the porcine carotid artery, medial 
smooth muscle cell proliferation is well advanced within 48 h 
of balloon injury (17): intimal thickening is apparent within 7 
days and peaks at approximately 28 days (18). In this study, 
high local concentrations of antioroliferative therapy were 
present for 7 to 14 days. It is possible that therapy for the full 
dur~~tio~~ of the study eriod. for example by retreatment 
with methotrexate at weekly intervals, may have been more 
effective in preventing neointimal thickening. The 
this study are consistent, however. with those of 
al. (19). In their study. which was also performed in a 
porcine model, methotrexate (1.25 mg 5 days/week orally or 
20 mglweek intramuscularly) and azathiopriue (25 mg/day 
orally), given throughout a 28-day study period, failed to 
inhibit neointimal thickening in coronary arteries after im- 
plantation uf oversized metallic stents. 
Composition of the neointima, A substantial proportion of 
the cells contributing to the thickness of the neointima may 
have been nonproliferating cells. In one study (20). approx- 
imately 50% of the smooth muscle cells that migrated from 
the media to the intima of balloon-injured rat carotid arteries 
were nondividing cells; and in this study, the lesions pro- 
duced frequently had a heavy infiltra;ion of cells with the 
morphologic appearances of macrophages. Mural thrombus 
appears to have played an important role in the genesis of the 
intimal thickening. Thrombus is known to stimulate smooth 
muscle cell proliferation directly (21,22), and hisrologic 
examination of material obtained by directional coronary 
atherectomy (23) suggests that incorporation of mural throm- 
bus plays a much greater role in the development of human 
restenotic lesions than has previously been appreciated. 
These findings suggest that restenosis  a heterogeneous 
response to injury and that in addition to antiproliferative 
servations (25) that 
~o~ife~at~o~ isr cell 
balloons to cause ep arterial injury in 
arteries and have 
extent of mural platelet deposition and thrombus formation 
red site. The apparent relation between the sever- 
proliferative response and the presence of focal 
of the internal elastic lamina has been noted 
rimental studies (30,31) and in 
es (32-34). A ~ote~t~a~~y more 
reliable means of inflicting injury on the vessel wall and of 
increasing the degree of intimal proliferation was recently 
described by Schwartz et al. (30,31). These investigators 
used oversized metallic 
porcine coronary arteries 
n rbe exkin! of intimal 1 
penetration in the arteri 
reducing the variability 
correction of the degree o 
e of 
e ev 
modes may therefore be more sensitive 
pharmacologic therapies. 
The principal limitations of this study are 
first, the relatively small number of pigs studied and the 
somewhat variable arterial response to injury. These factors 
limit the power of the y to detect small but potentially 
meaningful therapeutic cts. Second, only one drug dose 
was evaluated. The d chosen was determined by the 
maximal concenl ration of commercially available meth- 
otrexate. More concentrated solutions of methotrexate 
might have been more effective. Preliminary testing using 
tritium-labeled methotrexate suggeste , however, that the 
dose and concentration used were ade uate to achieve very 
high local methotrexate ievels; and for this reason, no higher 
concentration was tested. Third, because the size Qf tbe 
carotid arteries was nui measured directly or estimated 
angiographically, it is possible that the perforated balloon 
catheter may have been undersized in some pigs (lezding to 
loss sf neihotrexate into the systemic circulation) or over- 
d porcine carotid artery 
~ce~trat~o~ local intra- 
to prevent neoi~tjmal 
ctive i~~iibit~o~ of 
ing high local tissue concentrations 
We acknowledge the expert technical assistance of Phillip Sherman, PbD in 
the preparation of radioaclive tissues and the measurement of radiolabeled 
methotrexate activity. 
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